Bosh sahifaDIVISLAB • NSE
add
Divi's Laboratories Ltd
Yopilish kursi
5 977,10 ₹
Kunlik diapazon
5 980,00 ₹ - 6 056,95 ₹
Yillik diapazon
3 350,00 ₹ - 6 275,85 ₹
Bozor kapitalizatsiyasi
1,59 trln INR
Oʻrtacha hajm
499,58 ming
Narx/foyda
86,78
Dividend daromadliligi
0,50%
Asosiy maydon
NSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 23,38 mlrd | 22,47% |
Joriy xarajat | 7,52 mlrd | 5,17% |
Sof foyda | 5,10 mlrd | 46,55% |
Sof foyda marjasi | 21,81 | 19,64% |
Har bir ulushga tushum | 19,51 | 48,82% |
EBITDA | 7,15 mlrd | 49,58% |
Amaldagi soliq stavkasi | 29,36% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 36,02 mlrd | -0,25% |
Jami aktivlari | 155,86 mlrd | 9,12% |
Jami passivlari | 18,69 mlrd | 16,38% |
Umumiy kapital | 137,17 mlrd | — |
Tarqatilgan aksiyalar | 265,62 mln | — |
Narxi/balansdagi bahosi | 11,57 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 11,30% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 5,10 mlrd | 46,55% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.
In October 2024, Divi and his family were ranked 29th on Forbes list of India’s 100 richest tycoons, with a net worth of $9.2 billion. Wikipedia
Tashkil etilgan
12-okt, 1990
Sayt
Xodimlar soni
9 741
